FDA Clears First Fixed-Dose Combination Treatment for Gout FDA Clears First Fixed-Dose Combination Treatment for Gout

Duzallo combines lesinurad and allopurinol and is indicated for gout-associated hyperuricemia in patients for whom target serum uric acid levels are not achieved with allopurinol alone.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news